UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhancing Therapeutic Efficacy and Safety of Immune Checkpoint Inhibition for Bladder Cancer: A Comparative Analysis of Injectable vs. Intravesical Administration

International journal of molecular sciences, 2024-05, Vol.25 (9), p.4945

2024

Volltextzugriff (PDF)

Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist

The Journal of urology, 2024-01, Vol.211 (1), p.63-70

2024

Volltextzugriff (PDF)

Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents

Advances in therapy, 2022-06, Vol.39 (6), p.2515-2532

2022

Volltextzugriff (PDF)

The Impact of Polymerase Chain Reaction Urine Testing on Clinical Decision-Making in the Management of Complex Urinary Tract Infections

International journal of molecular sciences, 2024-06, Vol.25 (12), p.6616

2024

Volltextzugriff (PDF)

The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report

European urology, 2017-12, Vol.72 (6), p.942-949

2017

Volltextzugriff (PDF)

Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

Clinical cancer research, 2023-07, Vol.29 (13), p.2426-2434

2023

Volltextzugriff (PDF)

Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study

The Journal of urology, 2023-05, Vol.209 (5), p.890-900

2023

Volltextzugriff (PDF)

Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases

Targeted oncology, 2023-01, Vol.18 (1), p.95-103

2023

Volltextzugriff (PDF)

Review: Mammalian Target of Rapamycin (mTOR) Pathway Is Critical in Developing Most Renal Cell Tumors

Annals of clinical and laboratory science, 2023-01, Vol.53 (1), p.3

2023

Volltextzugriff (PDF)

Clear cell renal cell carcinoma cells show diffuse expression of phagocytotic markers through the identification of lysosome-rich eosinophilic granules

International urology and nephrology, 2024-02, Vol.56 (2), p.467-473

2024

Volltextzugriff (PDF)

Comparison of Polymerase Chain Reaction and Urine Culture in the Evaluation of Patients with Complex Urinary Tract Infections

Biology (Basel, Switzerland), 2024-04, Vol.13 (4), p.257

2024

Volltextzugriff (PDF)

A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer

Advances in therapy, 2020-12, Vol.37 (12), p.4910-4929

2020

Volltextzugriff (PDF)

The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data

The Journal of urology, 2020-04, Vol.203 (4), p.743-750

2020

Volltextzugriff (PDF)

Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data

The Journal of urology, 2021-02, Vol.205 (2), p.554-560

2021

Volltextzugriff (PDF)

Early continence outcomes of posterior musculofascial plate reconstruction during robotic and laparoscopic prostatectomy

BJU international, 2008-05, Vol.101 (9), p.1135-1139

2008

Volltextzugriff (PDF)

Diagnostic role of kidney injury molecule-1 in renal cell carcinoma

International urology and nephrology, 2019-11, Vol.51 (11), p.1893-1902

2019

Volltextzugriff (PDF)

National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle‐Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging

Cancer medicine (Malden, MA), 2018-11, Vol.7 (11), p.5370-5381

2018

Volltextzugriff (PDF)

The effect of time to castration-resistance on outcomes with abiraterone and enzalutamide in metastatic prostate cancer

Clinical genitourinary cancer, 2016-10, Vol.14 (5), p.381-388

2016

Volltextzugriff (PDF)

A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group

Urology Practice, 2024-01, Vol.11 (1), p.18-29

2024

Volltextzugriff (PDF)

Understanding the Millennial Physician

Urologic clinics of North America, 2021-05, Vol.48 (2), p.195-202

2021

Volltextzugriff (PDF)

Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques

Advances in radiation oncology, 2023-05, Vol.8 (3), p.101160-101160, Article 101160

2023

Volltextzugriff (PDF)

PD35-07 ANALYSIS OF DISCONTINUATION RATES AND CAUSES OF EARLY DISCONTINUATION OF NOVEL ORAL HORMONE THERAPY IN MEN WITH ADVANCED PROSTATE CANCER

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

Editorial Comment

The Journal of urology, 2024-06, Vol.211 (6), p.773-774

2024

Volltextzugriff (PDF)

MP87-01 DO PRIMARY HORMONAL THERAPY OUTCOMES PREDICT SUBSEQUENT RESPONSE TO ABIRATERONE OR ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER?

The Journal of urology, 2015-04, Vol.193 (4S)

2015

Volltextzugriff (PDF)

High-Intensity Focused Ultrasound (HIFU) Focal Therapy for Localized Prostate Cancer with MRI-US Fusion Platform

Advances in urology, 2021-12, Vol.2021, p.7157973-7

2021

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Enhancing Therapeutic Efficacy and Safety of Immune Checkpoint Inhibition for Bladder Cancer: A Comparative Analysis of Injectable vs. Intravesical Administration

Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist

Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents

The Impact of Polymerase Chain Reaction Urine Testing on Clinical Decision-Making in the Management of Complex Urinary Tract Infections

The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report

Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study

Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases

Review: Mammalian Target of Rapamycin (mTOR) Pathway Is Critical in Developing Most Renal Cell Tumors

Clear cell renal cell carcinoma cells show diffuse expression of phagocytotic markers through the identification of lysosome-rich eosinophilic granules

Comparison of Polymerase Chain Reaction and Urine Culture in the Evaluation of Patients with Complex Urinary Tract Infections

A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer

The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data

Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data

Early continence outcomes of posterior musculofascial plate reconstruction during robotic and laparoscopic prostatectomy

Diagnostic role of kidney injury molecule-1 in renal cell carcinoma

National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle‐Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging

The effect of time to castration-resistance on outcomes with abiraterone and enzalutamide in metastatic prostate cancer

A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group

Understanding the Millennial Physician

Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques

PD35-07 ANALYSIS OF DISCONTINUATION RATES AND CAUSES OF EARLY DISCONTINUATION OF NOVEL ORAL HORMONE THERAPY IN MEN WITH ADVANCED PROSTATE CANCER

Editorial Comment

MP87-01 DO PRIMARY HORMONAL THERAPY OUTCOMES PREDICT SUBSEQUENT RESPONSE TO ABIRATERONE OR ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER?

High-Intensity Focused Ultrasound (HIFU) Focal Therapy for Localized Prostate Cancer with MRI-US Fusion Platform

Suchergebnisse filtern